MyFinsight
Home
Blog
About
Net income (loss)
-$53,387K
(-150.12%↓ Y/Y)
Sanofi
$35,768K
Serum
$1,823K
Takeda
$215K
Other Partners
$38K
Supply Sales
$18,854K
Income (loss) before
income tax expense
-$51,676K
(-148.09%↓ Y/Y)
Income tax expense
$1,711K
(80.87%↑ Y/Y)
Other income, net
$8,919K
(-25.06%↓ Y/Y)
Licensing Royalties And
Other
$37,844K
Product
$18,854K
Income (loss) from
operations
-$54,906K
(-154.32%↓ Y/Y)
Total revenue
$56,698K
(-76.30%↓ Y/Y)
Interest expense
$5,689K
(3.10%↑ Y/Y)
Total expenses
$111,604K
(-19.23%↓ Y/Y)
Research and development
$70,693K
(-10.78%↓ Y/Y)
Selling, general, and
administrative
$26,665K
(-38.86%↓ Y/Y)
Cost of sales
$14,246K
(-7.04%↓ Y/Y)
Back
Back
Income Statement
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)
source: myfinsight.com